Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-01-15 @ 2:49 AM
Study NCT ID:
NCT04928105
Status:
UNKNOWN
Last Update Posted:
2022-05-31
First Post:
2021-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Senl-T7 CAR-T Cells for Treatment of Relapsed or Refractory CD7+ Lymphoma
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.